TY  - RPRT
TI  - Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation.
AU  - G Vlahovic
AU  - Z N Rabbani
AU  - J E Herndon
AU  - M W Dewhirst
AU  - Z Vujaskovic
PY  - 2006
DO  - 10.1038/sj.bjc.6603366
UR  - https://pubmed.ncbi.nlm.nih.gov/17003785/
ID  - 17003785
ER  -